Can colored light turn down pain? scientists scan brains to find out
NCT ID NCT07245303
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study investigates how colored light affects pain by scanning the brains of 60 people—half with chronic musculoskeletal pain (like fibromyalgia) and half healthy. Participants will view different light patterns while their brain activity is measured, and some will also receive a pressure pain stimulus. The goal is to understand the brain connections behind light-driven pain relief, not to test a treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- S-cone modulating visual stimulus (colored light)
- What this could lead to
- If successful, this could reveal how light reduces pain, potentially leading to new non-drug pain relief methods.
- What could go wrong
- This is an early-stage observational study with only 60 participants, focused on brain mechanisms, not treatment. Results may not lead to a practical therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2026
- Expected to finish
-
Jan 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria for participants with cMSP and healthy controls (n=30) * Adults ≥18 years of age. * Individuals who do not have any plans for medication or treatment changes for the next 3 months. * Participants must be willing and able to undergo an MRI. * Participants must not be claustrophobic * Participants must be alert and oriented and able to provide informed consent. * Individuals must be able to speak and read English. Inclusion Criteria for participants with cMSP only (n=30) * To be eligible, participants must have a score of ≥7 on the Widespread pain index (WPI) and ≥5 on the symptom severity scale (SSS), or 4-6 on the WPI and ≥9 on the SSS in the 2016 Fibromyalgia Questionnaire. * Pain symptoms must have been present for 3 months or longer. * Pain must be present in 4 out of 5 body regions. * Individuals enrolled will have an average pain severity ≥4 on the 0-10 NRS over the month prior to enrollment to recruit individuals with moderate to severe chronic MSP. Inclusion Criteria for Participants with Congenital Stationary Night Blindness (n=2) -2 additional participants without chronic MSP will be recruited with diagnosed congenital stationary night blindness Exclusion Criteria: * Presence of retinal vision disorders or conditions resulting in vision impairment. * Patient-reported photosensitivity, photophobia, or aversion (as may occur in autoimmune diseases such as systematic lupus erythematosus). * Disorders including uveitis, cataracts, color-blindness, history of seizure disorder. * Plans for analgesic treatment plan changes in next 3 months (surgery, analgesic medication changes, injections, pain procedures, etc). * Prisoner Status. * Pregnancy. * Contraindications to MRI imaging. These include the presence of implanted/embedded ferromagnetic materials, implanted medical devices that are not MRI compatible, and claustrophobia.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Congenital stationary night blindness are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of North Carolina at Chapel Hill
RECRUITINGChapel Hill, North Carolina, 27599, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Desk jobs and aching bodies: what Lawyers' activity levels reveal
- Can magnetic brain zaps ease the pain of a sleepless body?
- Can poor sleep make you hurt more? study probes Insomnia's link to pain
- Can a light bulb dial down chronic pain?
- Can a Hands-On nerve technique ease Fibromyalgia's grip?
- PET scans probe Brain's power plants in alcohol use disorder